Refine Results
  1. "S. Karger AG"
Formats
  1. Journal Article (139)
  2. Meeting Abstract (119)
  3. Book Section (16)
Groups
  1. Solid Tumor Oncology Division (49)
  2. Center for Hematologic Malignancies (39)
  3. Surgery (37)
  4. Hematologic Oncology, Division of (36)
  5. Hepatopancreaticobiliary Disease Management Team (30)
  6. Genitourinary Disease Management Team (28)

More Groups

People
  1. Lisa Bodei (13)
  2. Robert Motzer (13)
  3. Oscar Lin (12)
  4. Laura Tang (9)
  5. Ashfaq Marghoob (8)
  6. Andrew Zelenetz (7)

More People

Years
  1. 2018 (29)
  2. 2017 (25)
  3. 2016 (21)
  4. 2015 (13)
  5. 2014 (16)
  6. 2013 (13)

More Years

Publications
  1. Oncology Research and Treatment (58)
  2. Neuroendocrinology (27)
  3. Acta Cytologica (25)
  4. Onkologie (19)
  5. Acta Haematologica (18)
  6. Oncology (11)

More Publications

Publishers
  1. S. Karger AG (274)

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TDO2 overexpression is associated with cancer stem cells and poor prognosis in esophageal squamous cell carcinoma
    Journal Article

    Pham, Q. T.; Oue, N.; Sekino, Y.; Yamamoto, Y.; Shigematsu, Y.; Sakamoto, N.; Sentani, K.; Uraoka, N.; Yasui, W.
    Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials
    Meeting Abstract

    Haag, G. M.; Chen, L. T.; Kang, Y. K.; Satoh, T.; Kato, K.; Chung, H. C.; Kang, W. K.; Chao, Y.; Chen, J. S.; Ott, P. A.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Waidmann, O.; Merle, P.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Harris, W. P.; Nemunaitis, J.; Olteanu, S.; Sarker, D.; Tan, B. R.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Quantification of drug synergism in vivo exemplified for the combination of Taxotere and T607 against colon carcinoma HCT-116 xenograft tumors in nude mice
    Meeting Abstract

    Ulrich-Merzenich, G.; Fu, J.; Chou, J. H.; Chou, T. C.
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • CheckMate 227: Nivolumab (Nivo) + ipilimumab (Ipi) vs platinum-doublet chemotherapy (Chemo) as first-line treatment for advanced non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB)
    Meeting Abstract

    Reck, M.; Hellmann, M. D.; Paz-Ares Rodriguez, L.; Ramalingam, S. S.; Brahmer, J.; O'Byrne, K. J.; Bhagavatheeswaran, P.; Nathan, F.; Borghaei, H.
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial
    Meeting Abstract

    Waidmann, O.; Abou-Alfa, G. K.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Rimassa, L.; Ryoo, B. Y.; Cicin, I.; Merle, P.; Chen, Y. H.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Outcomes in patients (pts) who had received sorafenib (S) as the only prior systemic therapy in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Venerito, M.; Kelley, R. K.; Ryoo, B. Y.; Merle, P.; Park, J. W.; Bolondi, L.; Chan, S. L.; Lim, H. Y.; Baron, A.; Parnis, F.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Venerito, M.; Rimassa, L.; Cicin, I.; Blanc, J. F.; Klümpen, H. J.; Zagonel, V.; Tran, A.; Kim, S.; Lin, Z. Z.; Tam, V. C.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Clinicogenetic risk factors in patients receiving autologous stem-cell transplantation after frontline R-CHOP for advanced follicular lymphoma: An analysis from the GLSG2000 trial
    Meeting Abstract

    Alig, S.; Pastore, A.; Jurinovic, V.; Bararia, D.; Häbe, S.; Passerini, V.; Keay, W.; Hellmuth, J.; Rosenwald, A.; Klapper, W.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Ibrutinib/rituximab versus placebo/rituximab in Waldenström's macroglobulinemia (WM): Results of a randomized phase 3 trial
    Meeting Abstract

    Buske, C.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C. S.; Palomba, M. L.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save